147 related articles for article (PubMed ID: 3489157)
1. Study of the biological activities of toxic shock syndrome toxin-1. I. Proliferative response and interleukin 2 production by T cells stimulated with the toxin.
Uchiyama T; Kamagata Y; Wakai M; Yoshioka M; Fujikawa H; Igarashi H
Microbiol Immunol; 1986; 30(5):469-83. PubMed ID: 3489157
[TBL] [Abstract][Full Text] [Related]
2. Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin.
Uchiyama T; Kamagata Y; Yan XJ; Kohno M; Yoshioka M; Fujikawa H; Igarashi H; Okubo M; Awano F; Saito-Taki T
Clin Exp Immunol; 1987 Jun; 68(3):638-47. PubMed ID: 3498581
[TBL] [Abstract][Full Text] [Related]
3. Production of human and murine interleukin-2 by toxic shock syndrome toxin-1.
Micusan VV; Mercier G; Bhatti AR; Reiser RF; Bergdoll MS; Oth D
Immunology; 1986 Jun; 58(2):203-8. PubMed ID: 3486824
[TBL] [Abstract][Full Text] [Related]
4. Toxic shock syndrome toxin-1 induces inositol phospholipid turnover, protein kinase C translocation, and calcium mobilization in human T cells.
Chatila T; Wood N; Parsonnet J; Geha RS
J Immunol; 1988 Feb; 140(4):1250-5. PubMed ID: 2830336
[TBL] [Abstract][Full Text] [Related]
5. Endotoxin enhancement of toxic shock syndrome toxin 1-induced secretion of interleukin 1 by murine macrophages.
Beezhold DH; Best GK; Bonventre PF; Thompson M
Rev Infect Dis; 1989; 11 Suppl 1():S289-93. PubMed ID: 2784586
[TBL] [Abstract][Full Text] [Related]
6. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
[TBL] [Abstract][Full Text] [Related]
7. Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules.
Uchiyama T; Imanishi K; Saito S; Araake M; Yan XJ; Fujikawa H; Igarashi H; Kato H; Obata F; Kashiwagi N
Eur J Immunol; 1989 Oct; 19(10):1803-9. PubMed ID: 2583222
[TBL] [Abstract][Full Text] [Related]
8. Relative strength of the mitogenic and interleukin-2-production-inducing activities of staphylococcal exotoxins presumed to be causative exotoxins of toxic shock syndrome: toxic shock syndrome toxin-1 and enterotoxins A, B and C to murine and human T cells.
Uchiyama T; Kamagata Y; Yan XJ; Kawachi A; Fujikawa H; Igarashi H; Okubo M
Clin Exp Immunol; 1989 Feb; 75(2):239-44. PubMed ID: 2784735
[TBL] [Abstract][Full Text] [Related]
9. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome.
Bonventre PF; Heeg H; Cullen C; Lian CJ
Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600
[TBL] [Abstract][Full Text] [Related]
10. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R
J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria.
Calandra T; Spiegel LA; Metz CN; Bucala R
Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11383-8. PubMed ID: 9736745
[TBL] [Abstract][Full Text] [Related]
12. Proliferative response and cytokine production of bovine peripheral blood mononuclear cells induced by the superantigens staphylococcal enterotoxins and toxic shock syndrome toxin-1.
Yokomizo Y; Mori Y; Shimoji Y; Shimizu S; Sentsui H; Kodama M; Igarashi H
J Vet Med Sci; 1995 Apr; 57(2):299-305. PubMed ID: 7492650
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
[TBL] [Abstract][Full Text] [Related]
14. Synergistic induction of interleukin-1 by endotoxin and toxic shock syndrome toxin-1 using rat macrophages.
Beezhold DH; Best GK; Bonventre PF; Thompson M
Infect Immun; 1987 Dec; 55(12):2865-9. PubMed ID: 3500130
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the mitogenic effects of toxic shock toxin on human peripheral blood mononuclear cells in vitro.
Calvano SE; Quimby FW; Antonacci AC; Reiser RF; Bergdoll MS; Dineen P
Clin Immunol Immunopathol; 1984 Oct; 33(1):99-110. PubMed ID: 6332701
[TBL] [Abstract][Full Text] [Related]
16. Effects of 7,12-dimethylbenz[a]anthracene on the superantigen toxic shock syndrome toxin (TSST-1)-induced proliferation and antibody secretion by human lymphocytes.
Wood SC; Holsapple MP
Fundam Appl Toxicol; 1993 Apr; 20(3):280-7. PubMed ID: 8504901
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of toxic shock syndrome toxin-1-induced cytokine production and T cell activation by interleukin-10, interleukin-4, and dexamethasone.
Krakauer T
J Infect Dis; 1995 Oct; 172(4):988-92. PubMed ID: 7561220
[TBL] [Abstract][Full Text] [Related]
18. Relative activities of distinct isotypes of murine and human major histocompatibility complex class II molecules in binding toxic shock syndrome toxin 1 and determination of CD antigens expressed on T cells generated upon stimulation by the toxin.
Uchiyama T; Saito S; Inoko H; Yan XJ; Imanishi K; Araake M; Igarashi H
Infect Immun; 1990 Dec; 58(12):3877-82. PubMed ID: 2123824
[TBL] [Abstract][Full Text] [Related]
19. Induction of human interleukin-1 by toxic-shock-syndrome toxin-1.
Parsonnet J; Hickman RK; Eardley DD; Pier GB
J Infect Dis; 1985 Mar; 151(3):514-22. PubMed ID: 3871826
[TBL] [Abstract][Full Text] [Related]
20. Cytokine secretion induced by superantigens in peripheral blood mononuclear cells, lamina propria lymphocytes, and intraepithelial lymphocytes.
Sperber K; Silverstein L; Brusco C; Yoon C; Mullin GE; Mayer L
Clin Diagn Lab Immunol; 1995 Jul; 2(4):473-7. PubMed ID: 7583927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
